Highlights of ASCO 2026: how is cancer care evolving?

ASCO 2026 Recap: Five Days of ADCs, Bispecifics, Cell Therapy, and Precision Oncology

ASCO 2026 delivered important updates across hematologic malignancies, lung cancer, breast cancer, gastrointestinal cancers, melanoma, and several rare and difficult-to-treat tumors. Across the meeting, ADCs, bispecific antibodies, cell therapies, radioligand approaches, and increasingly precise biomarker-driven strategies remained at the center of oncology innovation. One presentation stood above the rest. During the Day 3 Plenary Session, Revo…

Highlights of ASCO 2026: how is cancer care evolving?

Labiotech heard from experts about the major trends and highlights in cancer care at ASCO 2026. The post Highlights of ASCO 2026: how is cancer care evolving?  appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is …